DarioHealth reported a significant decrease in revenue for Q4 2023 compared to the previous year, with a net loss also increasing. The company attributed the decrease in revenue to lower consumer and strategic partner channels. Despite this, DarioHealth’s CEO expressed optimism about the company’s pivot to a new business model, which includes the recent acquisition of Twill, a digital therapeutics company. The acquisition is expected to accelerate the company’s path to profitability and increase pro forma revenues in 2023. DarioHealth’s stock has seen a gradual decrease in value since 2017, but the company is hopeful that its financial profile will continue to improve in the coming year.
Source link
DarioHealth reports decreased revenue following Twill acquisition
